Patents by Inventor Christian Erck

Christian Erck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies targeting amyloid beta oligomers
    Patent number: 8795664
    Abstract: The invention relates to binding molecules capable of specifically recognizing soluble oligomers of N-terminal truncated A? starting with pyroglutamate (A??E), pharmaceutical compositions comprising same, and their respective therapeutic uses. Particularly, the invention relates to an antibody molecule capable of specifically recognizing A? oligomers, wherein said antibody binds and/or detects an epitope as bound and/or detected by antibody PG3-38 9D5H6 as deposited under DSM AC-C3056.
    Type: Grant
    Filed: June 3, 2011
    Date of Patent: August 5, 2014
    Assignees: Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin, Synaptic Systems Gesellschaft für Neurobiologische Forschung, Entwicklung und Produktion mbH
    Inventors: Thomas Bayer, Oliver Wirths, Henrik Martens, Christian Erck
  • MONOCLONAL ANTIBODIES TARGETING AMYLOID BETA OLIGOMERS
    Publication number: 20130295095
    Abstract: The invention relates to binding molecules capable of specifically recognizing soluble oligomers of N-terminal truncated A? starting with pyroglutamate (A??E), pharmaceutical compositions comprising same, and their respective therapeutic uses. Particularly, the invention relates to an antibody molecule capable of specifically recognizing A? oligomers, wherein said antibody binds and/or detects an epitope as bound and/or detected by antibody PG3-38 9D5H6 as deposited under DSM AC-C3056.
    Type: Application
    Filed: June 3, 2011
    Publication date: November 7, 2013
    Inventors: Thomas Bayer, Oliver Wirths, Henrik Martens, Christian Erck